Latest Industry Insights

To learn about the importance of the extracellular matrix and some of the limitations of current organoid culture systems, we spoke to Colin Sanctuary, CEO and founder of QGel, a spin-out from EPFL.

To gain an in-depth understanding of pesticide residue detection in food, and how improved quantitation technology is helping to overcome analytical challenges, we talked with Dr. Debadeep Bhattacharyya, Sr. Manager of Product Marketing at Thermo Fisher Scientific Inc.

We spoke to Dr Sacha Loiseau, developer of Cellvizio®, to learn more about optical biopsy and the benefits it can bring to the clinic.

Horizon and the Michael J Fox foundation have teamed up to generate a preclinical animal model of parkinson's disease.

David Taylor, CEO, MR Solutions talks to us about their development of dry-magnet MRI systems

CDI’s content of 81% of the human proteome (>23,000 proteins) is the largest human protein array in the world.

Promoting the adoption of in vitro toxicity testing is an important undertaking, so we should strive to overcome the barriers preventing its widespread adoption. Already, collaborative efforts have made progress in this regard, and research advances are increasingly demonstrating the potential of in vitro biomimetic liver models.

We took the opportunity to learn more about Unchained Lab's new product 'Hunky' and what it means for scientists developing biologics.

This new search tool ‘Researchably’ was recently awarded the prestigious Catalyst Grant. Designed to provide instant access to millions of resources, within one platform, it’s goal is ‘to make it easier for researchers to find the information they need’.

The field of toxicology as a whole is at a crossroads where current and future technologies are enabling better predictions of toxicity before a substance is released for human consumption or exposure. While a few barriers remain, we are making progress towards overcoming them, from both technical and policy perspectives.